Expression of polo-like kinase (PLK1) in thin melanomas: A novel marker of metastatic disease

Journal of Cutaneous Pathology

Volumn 29, Issue 6, 2002, Pages 354-358

  Kneisel, Lucas ^a   Strebhardt, Klaus ^a   Bernd, August ^a   Wolter, Manfred ^a   Binder, Angelika ^a   Kaufmann, Roland ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY; POLO LIKE KINASE 1; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; ONCOPROTEIN; POLO-LIKE KINASE 1; PROTEIN KINASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PROGNOSIS; PROTEIN EXPRESSION; RELIABILITY; THICKNESS; TUMOR VOLUME; COMPARATIVE STUDY; ENZYMOLOGY; MELANOMA; METABOLISM; MIDDLE AGED; PATHOLOGY; SKIN TUMOR; TUMOR RECURRENCE;

COMPARATIVE STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MELANOMA; MIDDLE AGE; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROTEIN KINASES; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T; CELL CYCLE PROTEINS; HUMANS; MIDDLE AGED; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS;

EID: 0035990398     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0560.2002.290605.x     Document Type: Article

References (25)

1. The incidence of malignant melanoma in the United States: Issues as we approach the 21st century
2. Prognosis in cutaneous melanoma: Tumor thickness as a guide to treatment
3. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe
4. Tumor thickness is not a prognostic factor in thin melanoma
5. Follow-up of patients with a thin melanoma
6. Metastases of thin melanomas
7. 'Thin' malignant melanoma, risk factors and clinical management
8. Recurrence potential of thin primary melanomas
9. Thin malignant melanomas with regression and metastases
10. Thin melanomas with unusual aggressive behavior. A report of nine cases
11. Thin malignant melanomas and recurrence potential
12. Is long-term follow-up justified after excision of thin melanoma (≤1.5 mm)? A retrospective analysis of 206 patients
13. Thin cutaneous malignant melanomas (≤1.5 mm)
14. Polo-like kinases: A team that plays throughout mitosis
15. Mitotic kinases as regulators of cell division and its checkpoints
16. Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors
17. Polo-like kinase, a novel marker for cellular proliferation
18. Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer
19. Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck
20. PLK (polo-like kinase), a new prognostic marker for oropharyngeal carcinomas
21. Prognostic significance of polo-like kinase expression in esophageal carcinoma
22. Polo-like kinase (PLK) espression in endometrial carcinoma
23. Prognostic value of polo-like kinase expression in melanomas
24. The Ki-67 protein: From the known and the unknown
25. Positivity of the proliferation marker Ki-67 in noncycling cells